ELVA revenueFY2025$63.83M
- FY YoY
- +43.1%
ELVA revenue was $63.83M for fiscal 2025 (ended Sep 30, 2025), up 43.1% from fiscal 2024. It rose in each of the last 3 fiscal years.
For fiscal 2025 (ended Sep 30, 2025), Electrovaya Inc. reported $63.83M of revenue and $3.36M of net income.
ELVA revenue was $63.83M for fiscal 2025 (ended Sep 30, 2025), up 43.1% from fiscal 2024. It rose in each of the last 3 fiscal years.
ELVA net income was $3.36M for fiscal 2025 (ended Sep 30, 2025), compared with -$1.49M in fiscal 2024.
| Line item | Sep 30, 2025 | Sep 30, 2024 | Sep 30, 2023 | Sep 30, 2022 |
|---|---|---|---|---|
| Revenue | $63.83M | $44.62M | $44.06M | $16.27M |
| Gross profit | $19.72M | $13.69M | $11.86M | $3.87M |
| Research and development | - | - | $3.38M | $3.43M |
| Selling, general and admin | - | - | $3.69M | $3.05M |
| Interest expense | $1.0K | $76.0K | $2.5K | $3.0K |
| Net income | $3.36M | -$1.49M | -$1.48M | -$9.21M |
| Diluted shares | - | - | 33.83B | 29.34B |
| Line item | Sep 30, 2025 | Sep 30, 2024 | Sep 30, 2023 | Sep 30, 2022 |
|---|---|---|---|---|
| Cash and equivalents | $1.59M | $159.0K | $1.00M | $600.0K |
| Inventory | $12.45M | $9.70M | $8.27M | $7.36M |
| Current assets | $41.96M | $29.42M | $25.91M | $14.79M |
| Total assets | $63.93M | $39.48M | $36.51M | $22.19M |
| Current liabilities | $10.08M | $28.53M | $26.61M | $22.66M |
| Total liabilities | $32.80M | $30.90M | $29.37M | $28.90M |
| Shareholders' equity | $31.13M | $8.59M | $7.15M | -$6.71M |
| Line item | Sep 30, 2025 | Sep 30, 2024 | Sep 30, 2023 | Sep 30, 2022 |
|---|---|---|---|---|
| Operating cash flow | $1.72M | $1.04M | -$4.9K | -$8.8K |
| Investing cash flow | -$12.04M | -$666.0K | -$903 | -$212 |
| Financing cash flow | $15.90M | -$629.0K | $6.2K | $7.9K |
| Stock-based compensation | $1.76M | $2.15M | $1.17M | $3.22M |
Source: XBRL data Electrovaya Inc. files with the SEC, latest filing dated Dec 19, 2025 (see filings on SEC EDGAR). Provided for information only, not investment advice. Check the filing before relying on a number.
Per-share figures are as filed. The filings show no stock split in these periods.
EPS growth is left out where the share count moved enough to suggest a split the filings do not show. Growth rates need a positive starting figure. CAGR is compound annual growth between fiscal years. The CSV holds every period on file, in full figures, from the same SEC filings.
Foreign private issuers file annual reports with the SEC, so there are no quarterly statements here.
| Company | Revenue | Growth | Net income | Net margin | Market cap |
|---|---|---|---|---|---|
| ELVA | $63.83M | +43.1% | $3.36M | 5.3% | $264.0M |
| ASML | €32.67B | +15.6% | €9.61B | 29.4% | $583.23B |
| LRCX | $26.13B | +33.4% | $8.45B | 32.3% | $276.45B |
| TMO | $47.35B | +8.3% | $7.07B | 14.9% | $267.38B |
| DE | $47.98B | +8.0% | $4.87B | 10.2% | $186.39B |
| DHR | $25.61B | +5.5% | $4.33B | 16.9% | $165.41B |
| ETN | $31.98B | +20.1% | $3.90B | 12.2% | $139.59B |
| JCI | $24.43B | +5.1% | $3.53B | 14.5% | $85.71B |
| ITW | $16.65B | +4.8% | $3.23B | 19.4% | $81.49B |